Your Article Summary
(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Takeda, Amgen to suspend trials of cancer drug
Corporate News Releases - The Healthcare Sales & Marketing Network, 11/20/08
Japan's Takeda Pharmaceutical Co and U.S. biotech firm Amgen Inc said they would suspend enrolment in the last-stage trials of a key cancer drug candidate following negative study results.
Today in Regulatory Issues...keeping you current
Receive free subspecialty "5-minute updates" via email
Avodart (dutasteride) Regulatory Update
GlaxoSmithKline, 10/02/09
Retigabine Regulatory Update
GlaxoSmithKline, 11/03/09
Beware of Tight 5010 Deadline
HealthDataManagement, 10/16/09
Article Search
Sponsor


See Latest Articles


